---
title: "Checkpoint Therapeutics CEO Sells Shares to Cover Tax Obligations"
date: "2025-02-12 10:10:00"
summary: "Reporter NameOliviero James F IiiRelationshipCEO, President and DirectorTypeSellAmount$64,027SEC FilingForm 4Checkpoint Therapeutics' CEO, President, and Director, James F. Oliviero III, sold a total of 19,564 shares of common stock on February 7 and February 10, 2025, for a total sale amount of $64,027. The sales were conducted at weighted average prices..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

| Reporter Name | Oliviero James F Iii |
| --- | --- |
| Relationship | CEO, President and Director |
| Type | Sell |
| Amount | $64,027 |
| SEC Filing | [Form 4](https://www.sec.gov/Archives/edgar/data/1651407/000110465925011656/xslF345X05/tm256253-1_4seq1.xml) |

Checkpoint Therapeutics' CEO, President, and Director, James F. Oliviero III, sold a total of 19,564 shares of common stock on February 7 and February 10, 2025, for a total sale amount of $64,027. The sales were conducted at weighted average prices of $3.41 and $3.15 per share, respectively, to satisfy tax withholding obligations related to the vesting of restricted shares. Following these transactions, Oliviero directly owns 3,775,019 shares of Checkpoint Therapeutics' common stock.

SEC Filing: [Checkpoint Therapeutics, Inc. [ CKPT ] - Form 4 - Feb. 11, 2025](https://www.sec.gov/Archives/edgar/data/1651407/000110465925011656/xslF345X05/tm256253-1_4seq1.xml)

[TradingView](https://www.tradingview.com/news/tradingview:119ae93165dc9:0-checkpoint-therapeutics-ceo-sells-shares-to-cover-tax-obligations/)
